NZ children’s nutrition brand Zeacura enters China market

NZ children's nutrition brand Zeacura enters China market

Summary

Zeacura, a New Zealand-origin children's nutrition brand owned by Auckland-based nutrition company Greenfield, has officially entered the mainland China market through a partnership with Xiuzheng Group. Five new children's nutrition products have been launched simultaneously, all manufactured and developed in New Zealand. Two of them, Zeacura's sensitivity-care and gut-health probiotics, are already sold in New Zealand.

Greenfield operates under the New Zealand Ministry of Primary Industries (MPI) Risk Management Programme (RMP) and holds GMP and HACCP certification from SGS. In MPI's Performance Based Verification (PBV), it has consistently reached the highest achievable Step 5 level (Ceiling Step 5) and passed unannounced verification. It is also listed on the MPI register of exporters to China with compliant export qualifications.

Xiuzheng Group is among the 2025 China Top 500 Private Enterprises and has long been involved in the infant and child health sector. Melissa Li, founder and CEO of Greenfield, said the Chinese market is an important part of Greenfield's global layout, and the company hopes to bring New Zealand's children's nutrition philosophy and products to China, working with Xiuzheng Group to offer Chinese families more children's nutrition choices. The five new products, built around the concept of 'pure nutrition, natural protection', cover needs including intestinal care, sensitivity management, immune support and daily dietary supplementation.

The two parties will gradually advance product introduction and channel cooperation based on feedback from the Chinese market.

Commentary

Zeacura's entry into the Chinese market is another case in China-New Zealand nutrition trade. As an Auckland company, Greenfield has been included in the MPI Risk Management Programme and obtained export qualifications to China. Its PBV has reached the highest Step 5 level, which is rare among small and medium-sized New Zealand nutrition companies.

China's children's nutrition market is growing at about 10 percent annually, but competition is intense. International brands such as Biostime and Nemans have already secured a certain share, while local brand Xiuzheng Pharmaceutical has deep accumulation in infant and child channels. Through this cooperation, Greenfield can quickly reach consumers in second- and third-tier cities by leveraging Xiuzheng's offline pharmacy and maternal and baby store networks, while Xiuzheng gains a high-end product line originating from New Zealand to enhance its brand image.

For NZ SMEs, this suggests that companies with high-level MPI certification and differentiated positioning (such as in the probiotics segment) can reduce market entry risks by cooperating with Chinese channel partners. However, it should be noted that China's new cross-border e-commerce regulations are tightening supervision over health foods, and the offline general trade path may be more prudent. Zeacura's first five products are all produced in New Zealand, emphasising 'pure nutrition', which aligns with Chinese parents' concerns about food safety, but if priced too high, they may face cost-effectiveness competition from local brands.

If brand awareness can be established in China in the future, it may encourage more New Zealand nutrition companies to follow suit.

Keywords: Zeacura, Greenfield, Xiuzheng Group, children's nutrition, New Zealand, MPI, RMP, probiotics, China market


AI illustration on MiDeer Observer

Source: QQ News

Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.

Leave a Reply

Your email address will not be published. Required fields are marked *